161 related articles for article (PubMed ID: 21347630)
1. Complete remission in a patient with metastatic mixed adenocarcinoma/extrapulmonary small cell carcinoma of the prostate.
Brammer JE; Lulla P; Lynch GR
Int J Clin Oncol; 2011 Dec; 16(6):722-5. PubMed ID: 21347630
[TBL] [Abstract][Full Text] [Related]
2. Small cell carcinoma of the prostate presenting with skin metastasis: a case report.
Cecen K; Karadag MA; Demir A; Kocaaslan R
J Med Case Rep; 2014 May; 8():146. PubMed ID: 24885487
[TBL] [Abstract][Full Text] [Related]
3. [Metastatic prostate cancer complicated with chronic disseminated intravascular coagulopathy causing acute renal failure, mimicking thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: pathomechanism, differential diagnosis and therapy related to a case].
Deme D; Ragán M; Kalmár K; Kovács L; Varga E; Varga T; Rakonczai E
Magy Onkol; 2010 Dec; 54(4):351-7. PubMed ID: 21163766
[TBL] [Abstract][Full Text] [Related]
4. [Combined small-cell carcinoma/adenocarcinoma of prostate: report of two cases].
Sakuma T; Yoshida T; Ohashi H; Nishimura K; Kawano K
Hinyokika Kiyo; 2007 Jul; 53(7):489-92. PubMed ID: 17702184
[TBL] [Abstract][Full Text] [Related]
5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
6. Does small-cell phenotype predict the natural history of prostate cancer? A case study in disease behavior.
Slovin SF
Nat Clin Pract Oncol; 2007 Sep; 4(9):551-4. PubMed ID: 17728713
[TBL] [Abstract][Full Text] [Related]
7. Clinico-pathologic characterisation of metastatic prostate cancer in the Radiotherapy and Oncology Department, Ahmadu Bello University Teaching Hospital, Zaria-Nigeria: 2006-2009.
Adewuyi SA; Mbibu NH; Samaila MO; Ketiku KK; Durosinmi-Etti FA
Niger Postgrad Med J; 2013 Mar; 20(1):45-51. PubMed ID: 23661210
[TBL] [Abstract][Full Text] [Related]
8. Combination of docetaxel, estramustine phosphate, and zoledronic acid in androgen-independent metastatic prostate cancer: efficacy, safety, and clinical benefit assessment.
Efstathiou E; Bozas G; Kostakopoulos A; Kastritis E; Deliveliotis C; Antoniou N; Skarlos D; Papadimitriou C; Dimopoulos MA; Bamias A
Urology; 2005 Jan; 65(1):126-30. PubMed ID: 15667877
[TBL] [Abstract][Full Text] [Related]
9. Flutamide withdrawal plus hydrocortisone resulted in clinical complete response in a patient with prostate carcinoma.
Figg WD; Kroog G; Duray P; Walther MM; Patronas N; Sartor O; Reed E
Cancer; 1997 May; 79(10):1964-8. PubMed ID: 9149024
[TBL] [Abstract][Full Text] [Related]
10. [Regression of a choroidal metastasis from prostate adenocarcinoma after hormonal therapy].
Barbón JJ; González-Tuero J; Gay LL; Pérez-García FJ; Sampedro A
Arch Soc Esp Oftalmol; 2007 Nov; 82(11):715-7. PubMed ID: 17979041
[TBL] [Abstract][Full Text] [Related]
11. Clinical features of neuroendocrine prostate cancer.
Conteduca V; Oromendia C; Eng KW; Bareja R; Sigouros M; Molina A; Faltas BM; Sboner A; Mosquera JM; Elemento O; Nanus DM; Tagawa ST; Ballman KV; Beltran H
Eur J Cancer; 2019 Nov; 121():7-18. PubMed ID: 31525487
[TBL] [Abstract][Full Text] [Related]
12. [Progression from adenocarcinoma to small cell carcinoma of the prostate during endocrinotherapy: a case report].
Maeno A; Kamoto T; Kitamura K; Kanno T; Okuno H; Terai A; Kakehi Y; Terachi T; Ogawa O; Matsushiro H
Hinyokika Kiyo; 2001 Aug; 47(8):591-3. PubMed ID: 11579603
[TBL] [Abstract][Full Text] [Related]
13. Impact of pretreatment factors, biopsy Gleason grade volume indices and post-treatment nadir PSA on overall survival in patients with metastatic prostate cancer treated with step-up hormonal therapy.
Miyamoto S; Ito K; Miyakubo M; Suzuki R; Yamamoto T; Suzuki K; Suzuki K; Yamanaka H
Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):75-86. PubMed ID: 21986985
[TBL] [Abstract][Full Text] [Related]
14. Long-term remission of metastatic small cell carcinoma of the prostate.
Ciszewski A; Shackleton D; Beer TM
Urology; 2008 Mar; 71(3):546.e3-4. PubMed ID: 18342209
[TBL] [Abstract][Full Text] [Related]
15. Serum calcitonin in small cell carcinoma of the prostate.
Sim SJ; Glassman AB; Ro JY; Lee JJ; Logothetis CJ; Liu FJ
Ann Clin Lab Sci; 1996; 26(6):487-95. PubMed ID: 8908318
[TBL] [Abstract][Full Text] [Related]
16. A more objective staging of advanced prostate cancer--routine recognition of malignant endocrine structures: the assessment of serum TPS, PSA, and NSE values.
Tarle M; Frković-Grazio S; Kraljić I; Kovacić K
Prostate; 1994; 24(3):143-8. PubMed ID: 7509485
[TBL] [Abstract][Full Text] [Related]
17. Complete remission of metastatic carcinoma of the prostate with bicalutamide withdrawal.
Kundranda MN; Muslimani A; Daw HA; Spiro TP
Clin Genitourin Cancer; 2007 Sep; 5(6):401-2. PubMed ID: 17956714
[TBL] [Abstract][Full Text] [Related]
18. [Small cell carcinoma of the prostate. Description of a case].
Candura SM; Fonte R; Cantale G; Paolotti D; Biscaldi G
Recenti Prog Med; 2000 Nov; 91(11):567-70. PubMed ID: 11125949
[TBL] [Abstract][Full Text] [Related]
19. Clinical and oncologic findings of extraprostatic extension on needle biopsy in
Chen JR; Zhao JG; Zhu S; Zhang MN; Chen N; Liu JD; Sun GX; Shen PF; Zeng H
Asian J Androl; 2020; 22(4):427-431. PubMed ID: 31424026
[TBL] [Abstract][Full Text] [Related]
20. Phase II evaluation of oral estramustine and oral etoposide in hormone-refractory adenocarcinoma of the prostate.
Pienta KJ; Redman B; Hussain M; Cummings G; Esper PS; Appel C; Flaherty LE
J Clin Oncol; 1994 Oct; 12(10):2005-12. PubMed ID: 7523606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]